Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study - Aikawa, Nadia E; Kupa, Leonard de Vinci Kanda; Pasoto, Sandra Gofinet; Shinjo, Samuel Katsuyuki; Pereira, Rosa Maria Rodrigues; Sartori, Ana Marli Christovam; Duarte, Alberto José da Silva; Antonangelo, Leila; Sabino, Ester Cerdeira; Menezes, Paulo Rossi; Kallas, Esper Georges; Silva, Clovis Artur Almeida da; et al. (Lancet rheumatology, 2022)